
Xcytrin 0.25mg Injection
Marketer
Vhb Life Sciences Inc
Salt Composition
Cetrorelix (0.25mg)
Overview Xcytrin 0.25mg Injection
Ganirelix 0.25mg Injection, an antagonist of gonadotropin-releasing hormone, treats female infertility. It suppresses premature egg release, preventing ovulation. Administered subcutaneously by a healthcare professional, self-injection is prohibited. Your doctor or nurse will guide you on proper home injection techniques. Dosage and frequency vary depending on individual needs and are determined by your physician to optimize treatment. Continue using this medication as prescribed. Common side effects include injection site reactions (redness, itching, or soreness), nausea, and vomiting. Rotate injection sites (e.g., abdomen) daily to minimize irritation. Report dizziness, fainting, abdominal pain, or severe vomiting immediately. Prior to treatment, inform your doctor of any kidney or liver conditions, or if breastfeeding. Disclose all other medications you are taking, as interactions may affect efficacy or alter the drug's action.
Uses of Xcytrin 0.25mg Injection
Inability to conceive in women
Major Benefits of Xcytrin 0.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Xcytrin 0.25mg Injection:
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Xcytrin 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Xcytrin 0.25mg Injection works:
During infertility treatment, women may experience premature egg release, yielding oocytes unsuitable for fertilization. Xcytrin 0.25mg Injection counteracts a natural hormone, thereby inhibiting this premature ovarian expulsion of eggs.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while using Xcytrin 0.25mg Injection. Seek medical advice.
PregnancyUNSAFE
Administration of Xcytrin 0.25mg Injection is contraindicated in pregnancy. Pregnant individuals should consult their physician, as research in animal and human subjects indicates substantial risks to fetal development.
Breast feedingUNSAFE
Administration of Xcytrin 0.25mg Injection is contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Administering Xcytrin 0.25mg Injection typically has no impact on driving capabilities.
KidneyCAUTION
Administering Xcytrin 0.25mg Injection to individuals with kidney impairment requires careful consideration and potential dosage modification. Seek medical advice before use. Xcytrin 0.25mg Injection is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Administering Xcytrin 0.25mg Injection to patients with hepatic impairment requires careful consideration. Dosage modification of Xcytrin 0.25mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Xcytrin 0.25mg Injection :
Should you inadvertently skip a dose of Xcytrin 0.25mg Injection, seek advice from your physician.
Facts to Know About Xcytrin 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Type | Peptide chains |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Actions | GnRH receptor antagonists |
